Home/Pipeline/AI for Lung Cancer

AI for Lung Cancer

Lung Cancer

ResearchActive

Key Facts

Indication
Lung Cancer
Phase
Research
Status
Active
Company

About Invenio Imaging

Invenio Imaging is a private, commercial-stage company pioneering real-time intraoperative histology through its NIO Laser Imaging System, which leverages Stimulated Raman Histology (SRH) technology. The company has commercialized its core hardware system and has begun integrating artificial intelligence, evidenced by its CE-marked NIO Glioma Reveal algorithm for brain tumor surgery in the EU. Invenio targets multiple surgical subspecialties, including neurosurgery, pulmonology, and urology, with the goal of improving surgical decision-making and patient outcomes by providing rapid, on-site tissue analysis without destroying the sample.

View full company profile

Therapeutic Areas

Other Lung Cancer Drugs